|
Status |
Public on Jan 24, 2014 |
Title |
Novel microRNA-like viral small regulatory RNAs arising during human hepatitis A virus infection |
Organisms |
Homo sapiens; Hepatovirus A |
Experiment type |
Non-coding RNA profiling by high throughput sequencing
|
Summary |
MicroRNAs (miRNAs), including host miRNAs and viral miRNAs, play vital roles in regulating host-virus interactions. DNA viruses encode miRNAs that regulate the viral life cycle. However, it is generally believed that cytoplasmic RNA viruses do not encode miRNAs, owing to inaccessible cellular miRNA processing machinery. Here, we provide a comprehensive genome-wide analysis and identification of miRNAs that were derived from hepatitis A virus (HAV; Hu/China/H2/1982), which is a typical cytoplasmic RNA virus. Using deep-sequencing and in silico approaches, we identified 2 novel virally encoded miRNAs, named hav-miR-1-5p and hav-miR-2-5p. Both of the novel virally encoded miRNAs were clearly detected in infected cells. Analysis of Dicer enzyme silencing demonstrated that HAV-derived miRNA biogenesis is Dicer dependent. Furthermore, we confirmed that HAV mature miRNAs were generated from viral miRNA precursors (pre-miRNAs) in host cells. Notably, naturally derived HAV miRNAs were biologically and functionally active and induced post-transcriptional gene silencing (PTGS). Genomic location analysis revealed novel miRNAs located in the coding region of the viral genome. Overall, our results show that HAV naturally generates functional miRNA-like small regulatory RNAs during infection. This is the first report of miRNAs derived from the coding region of genomic RNA of a cytoplasmic RNA virus. These observations demonstrate that a cytoplasmic RNA virus can naturally generate functional miRNAs, as DNA viruses do. These findings also contribute to improved understanding of host-RNA virus interactions mediated by RNA virus-derived miRNAs.
|
|
|
Overall design |
Examination of small RNA populations in KMB17 cells infected by human hepatitis A virus genotype IA (isolate H2) (21 days post-infected cells) and mock-infected KMB17 cells (21 days mock-infected control cells).
|
|
|
Contributor(s) |
Shi J, Hu Y |
Citation(s) |
25002121 |
|
Submission date |
Jan 23, 2014 |
Last update date |
May 15, 2019 |
Contact name |
Jiandong Shi |
E-mail(s) |
dongdong9286@yeah.net
|
Organization name |
Institute of Medical Biology
|
Department |
Department of Vaccine Research
|
Street address |
935# Jiaoling Road
|
City |
Kunming |
State/province |
Yunnan |
ZIP/Postal code |
650118 |
Country |
China |
|
|
Platforms (2) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL18215 |
Illumina HiSeq 2000 (Hepatitis A virus; Homo sapiens) |
|
Samples (2) |
GSM1313963 |
Small RNA deep sequencing of KMB17 cells infected with human hepatitis A virus 21 days post-infection |
GSM1313964 |
Small RNA deep sequencing of mock-infected KMB17 cells 21 days post-infection |
|
Relations |
BioProject |
PRJNA236334 |
SRA |
SRP035638 |